Documents Updates from ASH 2010: Second and Third Generation TKIs for CML Compound-Specific Toxicities of TKIs...

Slide 1 Updates from ASH 2010: Second and Third Generation TKIs for CML Compound-Specific Toxicities of TKIs in CML Michael J. Mauro MD Slide 2 IRIS 8-Year Update – 37%*…

Documents CML TKIs – where are we up to? Steve O’Brien Northern Institute for Cancer Research Newcastle...

CML TKIs – where are we up to? Steve O’Brien Northern Institute for Cancer Research Newcastle University Medical School Newcastle, March 2013 Second generation TKIs are…

Documents Interest in Topics Related to the Treatment of Patients with CML (Percent Responding 9 or 10)

Chronic Myeloid Leukemia (CML) Susan M OâBrien, MD IRIS 8-Year Update: Outcome After Imatinib Deininger M et al; Blood 2009;114(22):462. Nilotinib vs Imatinib in Newly Dx…